BASELINE CHARACTERISTICS OF PATIENTS ON MEDIUM- VS HIGH-DOSE INHALED CORTICOSTEROIDS IN PATIENTS INITIATING DUPILUMAB IN A REAL-WORLD CLINICAL SETTING: THE RAPID REGISTRY

被引：0
|
作者：
Lugogo, Njira L.
Cote, Andreanne
Bourdin, Arnaud
Peters, Anju T.
Bacharier, Leonard B.
Xia, Changming
Pandit-Abid, Nami
Jacob-Nara, Juby A.
Sacks, Harry
Rowe, Paul J.
Deniz, Yamo
Soliman, Mena
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.06.2843
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4721A / 4724A
页数：4
相关论文
共 50 条
  • [31] Real-World Demographic and Clinical Characteristics of Patients Initiating Avatrombopag in the US: The Real-AVA Study
    Kolodny, Scott
    Oladapo, Abiola
    Vredenburg, Michael
    Jamieson, Brian
    Swallow, Elyse
    Goldschmidt, Debbie
    Zichlin, Miriam L.
    Lopez, Priscilla
    Davidson, Mikhail
    Yee, John
    BLOOD, 2022, 140 : 13150 - 13151
  • [32] Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia
    Cheng, Shih-Lung
    Su, Kang-Cheng
    Wang, Hao-Chien
    Perng, Diahn-Warng
    Yang, Pan-Chyr
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 601 - 607
  • [33] Comparison of diabetic patients' baseline characteristics in clinical trials versus real-world settings
    Ehlken, Birgit
    Schokker, Emile
    Kostev, Karel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 157 - 157
  • [34] Demographic and clinical profiles of type 2 diabetes mellitus patients initiating sitagliptin in the real-world setting
    Pawaskar, Manjiri
    Liu, Jinan
    Rajpathak, Swapnil
    Iglay, Kristy
    Engel, Samuel S.
    Hannachi, Hakima
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (07) : 1247 - 1253
  • [35] Characteristics of Patients With Crohn's Disease Initiating Vedolizumab Therapy in Real-World Clinical Practice
    Khalid, Javaria M.
    Reynolds, Matthew
    Alam, Naufil
    Don, O'Hara
    Smyth, Michael D. L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S773 - S774
  • [36] DUPILUMAB PLUS MEDIUM-DOSE INHALED CORTICOSTEROID IMPROVES OUTCOMES COMPARED WITH PLACEBO PLUS HIGH-DOSE INHALED CORTICOSTEROID IN PEDIATRIC PATIENTS WITH UNCONTROLLED ASTHMA
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Papadopoulos, Nikolaos
    Guilbert, Theresa
    Xia, Changming
    Soliman, Mena
    Ledanois, Olivier
    Rowe, Paul J.
    Deniz, Yamo
    Jacob-Nara, Juby A.
    Sacks, Harry
    CHEST, 2024, 166 (04) : 4806A - 4808A
  • [37] Baseline Characteristics of Type 2 Diabetes Mellitus Patients Initiating DPP-4 Inhibitor in Real-World Russian Clinical Settings
    Emirova, Aida
    Zilov, Alexey
    DIABETES, 2013, 62 : A706 - A706
  • [38] The effect of baseline characteristics on clinical efficacy of liraglutide in patients treated with high-dose insulin
    Pokala, Nagendra
    Adams-Huet, Beverley
    Li, Xilong
    Harrison, Lindsay B.
    Vanderheiden, Anna
    Lingvay, Ildiko
    DIABETES OBESITY & METABOLISM, 2017, 19 (10): : 1454 - 1457
  • [39] Real-world clinical profiles of patients with alpha-mannosidosis: Baseline evaluations from the SPARKLE registry
    Muschol, Nicole M.
    Guffon, Nathalie
    Ballabeni, Andrea
    Borgwardt, Line
    Lund, Allan
    Gil-Campos, Mercedes
    Dona, Francesca
    Hennermann, Julia B.
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 91 - 91
  • [40] The Effect of Baseline Characteristics on Clinical Efficacy of Liraglutide in Patients Treated with High-Dose Insulin
    Pokala, Nagendra
    Adams-Huet, Beverley
    Li, Xilong
    Harrison, Lindsay B.
    Vanderheiden, Anna
    Lingvay, Ildiko
    DIABETES, 2017, 66 : A291 - A291
12345